| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |